Literature DB >> 5309915

[Proteinuria, proteinaemia, and serum transaminase activity in 23 confirmed cases of yellow fever].

J L Oudart, M Rey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5309915      PMCID： PMC2427514     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN： 0042-9686            Impact factor:   9.408


× No keyword cloud information.
  5 in total

1.  Clinical pathology of yellow fever.

Authors:  N W ELTON; A ROMERO; A TREJOS
Journal:  Am J Clin Pathol       Date:  1955-02       Impact factor: 2.493

2.  STUDIES IN THE ACQUISITION OF IMMUNITY OF PLASMODIUM FALCIPARUM INFECTIONS IN AFRICA.

Authors:  I A MCGREGOR
Journal:  Trans R Soc Trop Med Hyg       Date:  1964-01       Impact factor: 2.184

3.  A clinico-pathological study of yellow fever in Nigeria.

Authors:  F N MACNAMARA
Journal:  West Afr Med J       Date:  1957-12

4.  Transaminase activity in human blood.

Authors:  A KARMEN; F WROBLEWSKI; J S LADUE
Journal:  J Clin Invest       Date:  1955-01       Impact factor: 14.808

5.  [The value of systematic determination of the serum transaminases of blood donors in a transfusion center. (Preliminary notes)].

Authors:  V Schwarzmann; J Linhard; G Diebolt; N Berthaux
Journal:  Bull Soc Med Afr Noire Lang Fr       Date:  1965
  5 in total
  7 in total

1.  Yellow Fever: Factors Associated with Death in a Hospital of Reference in Infectious Diseases, São Paulo, Brazil, 2018.

Authors:  Ana Freitas Ribeiro; Roberta Figueiredo Cavalin; Jamal Muhamad Abdul Hamid Suleiman; Jessica Alves da Costa; Marileide Januaria de Vasconcelos; Ceila Maria Sant'Ana Málaque; Jaques Sztajnbok
Journal:  Am J Trop Med Hyg       Date:  2019-07       Impact factor: 2.345

Review 2.  Gastrointestinal and Hepatic Manifestations of Ebola Virus Infection.

Authors:  Nisha Sharma; Mitchell S Cappell
Journal:  Dig Dis Sci       Date:  2015-05-14       Impact factor: 3.199

3.  [3 cases of yellow fever contracted in Senegal].

Authors:  J P Digoutte; H Plassart; J J Salaün; G Heme; L Ferrara; M Germain
Journal:  Bull World Health Organ       Date:  1981       Impact factor: 9.408

4.  Present status of yellow fever: memorandum from a PAHO meeting.

Authors: 
Journal:  Bull World Health Organ       Date:  1986       Impact factor: 9.408

5.  Hepatitis Rebound after Infection with Yellow Fever Virus.

Authors:  Blandine Denis; David Chirio; Diane Ponscarme; Ségolène Brichler; Nathalie Colin de Verdière; François Simon; Jean-Michel Molina
Journal:  Emerg Infect Dis       Date:  2019-06-17       Impact factor: 6.883

6.  Late-Relapsing Hepatitis after Yellow Fever.

Authors:  Izabela Maurício Rezende; Leonardo Soares Pereira; Jordana Rodrigues Barbosa Fradico; Marcelo Antônio Pascoal Xavier; Pedro Augusto Alves; Ana Carolina Campi-Azevedo; Elaine Speziali; Lívia Zignago Moreira Dos Santos; Natalia Soares Albuquerque; Indiara Penido; Tayrine Araujo Santos; Ana Paula Dinis Ano Bom; Andrea Marques Vieira da Silva; Camilla Bayma Fernandes; Carlos Eduardo Calzavara; Erna Geessien Kroon; Olindo Assis Martins-Filho; Andréa Teixeira-Carvalho; Betânia Paiva Drumond
Journal:  Viruses       Date:  2020-02-17       Impact factor: 5.048

7.  Risk Factors for Acute Kidney Injury and Death in Patients Infected With the Yellow Fever Virus During the 2018 Outbreak in São Paulo, Brazil.

Authors:  Márcia Fernanda Arantes; Victor Faria Seabra; Paulo Ricardo Gessolo Lins; Camila Eleuterio Rodrigues; Bernardo Vergara Reichert; Marcelo Augusto Duarte Silveira; Ho Yeh Li; Luiz Marcelo Malbouisson; Lúcia Andrade
Journal:  Kidney Int Rep       Date:  2021-12-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.